Efficacy of Teeth Whitening Product Offerings in Adults

NCT ID: NCT04124068

Last Updated: 2020-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2019-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a 30 day randomized, parallel comparative trial where participants with tooth shade of C2 or darker will be assigned to one of five groups. The participants will be evaluated for the difference in tooth shade, as determined by the digital VITA Easyshade V (provided by GLO) before the respective whitening regimen (baseline), immediately following the treatment period, and at 30 days (\~4 weeks) from end of the treatment intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tooth Discoloration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GLO Science Professional Chairside Teeth Whitening

Group Type EXPERIMENTAL

Hydrogen peroxide teeth whitening gel

Intervention Type OTHER

Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

GLO Science Professional Teeth Whitening Device

Intervention Type DEVICE

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

GLO Science Professional At-Home Teeth Whitening Device

Group Type EXPERIMENTAL

Hydrogen peroxide teeth whitening gel

Intervention Type OTHER

Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

GLO Science Professional Teeth Whitening Device

Intervention Type DEVICE

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

GLO Brilliant At-Home Teeth Whitening Device

Group Type EXPERIMENTAL

Hydrogen peroxide teeth whitening gel

Intervention Type OTHER

Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

GLO Brilliant Teeth Whitening Device

Intervention Type DEVICE

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

GLO Lit At-Home Teeth Whitening Device

Group Type EXPERIMENTAL

Hydrogen peroxide teeth whitening gel

Intervention Type OTHER

Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

GLO Lit Teeth Whitening Device

Intervention Type DEVICE

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

GLO Lit Whitening GLO Vials

Group Type EXPERIMENTAL

Hydrogen peroxide teeth whitening gel

Intervention Type OTHER

Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hydrogen peroxide teeth whitening gel

Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

Intervention Type OTHER

GLO Brilliant Teeth Whitening Device

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

Intervention Type DEVICE

GLO Lit Teeth Whitening Device

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

Intervention Type DEVICE

GLO Science Professional Teeth Whitening Device

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provide written informed consent to participate in the study.
* Be 18 to 65 years of age.
* Agree not to participate in any other oral/dental product studies during the trial.
* Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed.
* Agree to refrain from the use of any other teeth whitening products once assigned to a treatment group.
* Agree to refrain from the use of any oral care products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).
* Agree to return for all scheduled visits and follow study procedures.
* Be in good general health, as determined by the investigator/designee based on a review of the health history/update for participation in the study.
* Have at least 4 gradable maxillary anterior teeth ( canine to canine) with a Vita Shade average score of C2 or darker.
* Be willing to refrain from consuming stain-causing food and beverages (i.e., coffee, tea, red wine, berries, etc.) during the initial treatment duration (treatment period excluding the 4 week follow up).
* Be a current or recent non-smoker (no smoking for at least 3 months).

Exclusion Criteria

* Are undergoing treatment for gingivitis, periodontitis, or caries.
* Presence of self-reported tooth sensitivity.
* Present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
* Have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth ( canine to canine) or mandibular anterior teeth.
* Have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
* Present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
* Have meaningful malocclusion that would impact treatment or ease of viewing/scoring maxillary anterior teeth.
* Have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypocalcification.
* Have any known allergies to over-the-counter oral hygiene/whitening products.
* Have any known allergies to the trial product ingredients.
* Are pregnant and/or breastfeeding.
* Are current smokers.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arizona School of Dentistry & Oral Health, A. T. Still University

UNKNOWN

Sponsor Role collaborator

Glo Science, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ann Spolarich, RDH, PhD

Role: PRINCIPAL_INVESTIGATOR

Arizona School of Dentistry & Oral Health, A. T. Still University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arizona School of Dentistry & Oral Health

Mesa, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GLO-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.